SnET2: PDTI began a Phase I/II dose escalation study of SnET2.

By WIR Staff | May 13, 1996 | 7:00 AM GMT

PDT Inc. (PDTI), Santa Barbara, Calif.
Product: SnET2, photodynamic

Read the full 96 word article

How to gain access

Continue reading with a
two-week free trial.